Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma

This study has been completed.
Sponsor:
Collaborator:
Christus Stehlin Foundation for Cancer Research
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00947739
First received: July 24, 2009
Last updated: June 16, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)